Provided by Tiger Trade Technology Pte. Ltd.

MSA Safety

196.76
+2.101.08%
Post-market: 196.760.00000.00%16:10 EST
Volume:217.90K
Turnover:42.68M
Market Cap:7.70B
PE:27.71
High:197.55
Open:195.17
Low:192.12
Close:194.66
52wk High:197.55
52wk Low:127.86
Shares:39.15M
Float Shares:36.68M
Volume Ratio:1.07
T/O Rate:0.59%
Dividend:2.08
Dividend Rate:1.06%
EPS(TTM):7.10
EPS(LYR):7.24
ROE:23.35%
ROA:10.99%
PB:5.93
PE(LYR):27.19

Loading ...

BRIEF-MSA Safety Q4 Adjusted EPS USD 2.38 Vs. IBES Estimate USD 2.26

Reuters
·
7 mins ago

MSA Safety Inc - Expects Mid-Single Digit FY Organic Sales Growth in 2026

THOMSON REUTERS
·
8 mins ago

MSA Safety Q4 Sales USD 511 Million VS. Ibes Estimate USD 508.1 Million

THOMSON REUTERS
·
8 mins ago

MSA Safety Announces Fourth Quarter and Full-Year 2025 Results

THOMSON REUTERS
·
8 mins ago

MSA Safety posts FY2025 net income of USD 279 million, up 15%

Reuters
·
9 mins ago

MSA Safety Currently Up Eight Consecutive Days, on Pace for Longest Winning Streak Since June 2023 -- Data Talk

Dow Jones
·
2 hours ago

Atrium Research Sticks to Its Buy Rating for Mineros SA (MSA)

TIPRANKS
·
Feb 09

Press Release: Mineros S.A. Announces 2026 Guidance: A Disciplined Approach to Production Growth and Strategic Expansion

Dow Jones
·
Feb 06

JDI Forges Partnership with Firm for Glass Substrate Co-Development and Mass Production Supply

Deep News
·
Feb 04

Earning Preview: MSA Safety this quarter’s revenue is expected to decrease by 2.30%, and institutional views are bullish

Earnings Agent
·
Feb 04

JPMorgan Initiates Coverage on MSA Safety With Neutral Rating, $200 Price Target

MT Newswires Live
·
Feb 03

MSA Safety initiated with a Neutral at JPMorgan

TIPRANKS
·
Feb 03

Alterity Therapeutics: Appendix 4C – Q2 FY26 Quarterly Cash Flow Report & Corporate Update

GlobeNewswire
·
Jan 30

Alterity Sharpens ATH434 Phase 3 Plans as Phase 2 MSA Data Strengthen

TIPRANKS
·
Jan 30

MSA Safety Inc. to Host Earnings Conference Call

Reuters
·
Jan 30

MSA Safety Unveils Advanced Refrigerant Monitors at AHR Expo

Reuters
·
Jan 29

Lantronix and Safe Pro Group Launch Partnership to Advance AI-Driven Edge Intelligence for Defense and Autonomous Systems

GlobeNewswire
·
Jan 27

Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026

GlobeNewswire
·
Jan 21

Alterity Therapeutics Advances Lead MSA Drug Toward Phase 3 After Strong Phase 2 Data

TIPRANKS
·
Jan 21

Trump 2.0: One Year In - The Fracturing of America's Rural Voters

Deep News
·
Jan 20